The 105.6% three‑month return—outpacing the S&P by nearly 10%—is the standout, signaling that investors are betting on accelerated adoption of PureCycle's low‑carbon polymer solution and likely pricing in upcoming capacity expansions.
Investors should monitor execution risk: if PCT fails to achieve projected plant capacity (currently slated at 100,000 tons/yr) within the next 12‑18 months, its annualized return could revert toward the index's negative trajectory, potentially eroding the recent 21.4% three‑year edge.
The recent 2.55% institutional inflow is modest relative to the 75.66% existing ownership; any reversal—e.g., a 5% outflow—could trigger sharp selling pressure given the stock's high beta and limited free float, magnifying downside risk.
Despite negligible top‑line growth, the extreme R&D intensity—over two‑thirds of revenue—signals a strategic bet on proprietary recycling technology; if successful, this could unlock high‑margin licensing revenues that would dramatically improve earnings potential.
The net margin’s magnitude (over –2,100%) quantifies a severe profitability deficit; without rapid scaling or cost reductions, the company will need continuous capital infusions, heightening dilution risk and jeopardizing long‑term financial viability.
The 5-fold rise in the equity multiplier is the dominant driver of the ROE collapse, revealing that PureCycle’s aggressive debt financing is magnifying losses rather than funding profitable growth, a red flag for investors seeking stable returns.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | -397.9 | -2185.1 | 0.01 | 20.11 | -20.2 | -19.9 | -19.8 |
| 2024 | -160.2 | 4.42 | -21.0 | -20.5 | -36.2 | ||
| 2023 | -24.2 | 2.47 | -14.7 | -11.6 | -9.8 | ||
| 2022 | -16.6 | 1.69 | -11.3 | -9.9 | -9.8 | ||
| 2021 | -20.3 | 1.74 | -13.1 | -11.1 | -11.7 | ||
| 2020 | -47.4 | 3.65 | -35.1 | -9.9 | -13.0 | ||
| 2019 | -840.1 | 13.98 | -78.9 | -78.9 | -60.1 | ||
| 2018 | -66.3 | 4.16 | -19.7 | -19.7 | -15.9 |
The 88‑day CCC translates into an estimated $45 million of cash locked in working capital (based on average daily sales), which constrains liquidity and heightens refinancing risk if operating losses persist.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 40308 | 24 | 88 | 31197 | 24 | 88 |
| 2024 | 85 | 0 | 69 | 16 | ||
| 2023 | 137 | 0 | 56 | 81 | ||
| 2022 | 0 | 0 | 23 | -23 | ||
| 2021 | 0 | 0 | 48 | -48 | ||
| 2020 | 0 | 0 | 45 | -45 | ||
| 2019 | 0 | 0 | 145 | -145 | ||
| 2018 | 0 | 0 | 1438 | -1438 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $923M | $877M | $46M | $776M | $619M | $157M | $198M | $88M |
| 2024 | $798M | $618M | $180M | $401M | $386M | $16M | $54M | $91M |
| 2023 | $1039M | $619M | $420M | $544M | $470M | $73M | $163M | $56M |
| 2022 | $861M | $350M | $511M | $250M | $186M | $64M | $236M | $38M |
| 2021 | $665M | $283M | $382M | $233M | $199M | $33M | $345M | $38M |
| 2020 | $408M | $296M | $112M | $262M | $198M | $64M | $65M | $33M |
| 2019 | $33M | $31M | $2M | $20M | $20M | $0M | $3M | $10M |
| 2018 | $26M | $20M | $6M | $15M | $15M | $0M | $1M | $5M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $-143M | $-54M | $324M | $-41M | $-184M | $-5M | |
| 2024 | $-145M | $-7M | $-109M | $-56M | $-200M | $-2M | |
| 2023 | $-95M | $-102M | $272M | $-154M | $-249M | $-1M | |
| 2022 | $-65M | $-218M | $248M | $-287M | $-353M | $-2M | |
| 2021 | $-55M | $-306M | $293M | $-137M | $-192M | $-2M | |
| 2020 | $-18M | $-30M | $378M | $-30M | $-48M | ||
| 2019 | $-6M | $-6M | $12M | $-6M | $-12M | ||
| 2018 | $-5M | $-11M | $17M | $-11M | $-17M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net